Transmission of Human T-Lymphotropic Virus Type I to Donor-Origin T Cells During Allogeneic Hematopoietic Stem Cell Transplantation

Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study

“…Cook et al demonstrated that donor-originated T-cells with human T-lymphotropic virus type 1 resulted in the infection of three allo-HSCT recipients [ 11 ]. Similarly, studies have shown that a small number of patients exhibit donor-derived T-cell leukemia/lymphoma after receiving allo-HSCT from donors positive for human T-cell lymphotropic virus type 1 [ 12 , 13 , 14 ]. Moreover, memory-like NK cells could also be transplanted from donor to recipient, as evidenced by several studies [ 15 , 16 ].…”